Delivery Order SPE2DB22D2218-SPE2DB25FR2TR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $3,135.58. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 13, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $2,716.90, with completion targeted for July 21, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL units, valued at $3,037.93. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. Phytonadione, commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for Phytonadione 1 mg/0.5 mL syringes with a contract ceiling value of $6,851.88. This is a firm fixed price delivery order with an ultimate completion date of June 4, 2025, and represents a non-set-aside competitive award. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a critical...
- The Defense Logistics Agency awarded a $21,587.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for phytonadione 1 mg/0.5 mL syringes with an ultimate completion date of September 9, 2025. Phytonadione, commonly known as vitamin K1, is a critical pharmaceutical used for blood clotting disorders and vitamin K deficiency treatment. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,774.99 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.32 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes (0.5 mL units). This is a firm fixed-price delivery order with no set-aside designation, executed on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $10,492.26 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL units. This contract, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as vitamin K1,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $20,559.12. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $1,452.64 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Phytonadione 10 mg/ml ampules. This is a firm fixed price contract with no set-aside designation, classified as a child contract under a larger vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. Phytonadione, commonly known as Vitamin K1, is a critical...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR2TRDelivery Order
The Defense Logistics Agency awarded a $2,132.69 delivery order to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on June 13, 2025, with an ultimate completion date of June 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used to treat vitamin K deficiency and support blood coagulation in military and veteran healthcare settings. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. As one of the government's primary pharmaceutical vendors, AmerisourceBergen leverages this comprehensive IDC to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare programs globally. The company's selection demonstrates its established capability to meet federal procurement requirements for specialized pharmaceutical products across multiple therapeutic domains and delivery timelines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 6/13/25 |